|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| Research and development | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income (expenses): | |
| Interest income | |
| Other income | |
| Interest expense | |
| Total other income, net | |
| Loss before income taxes | |
| Income tax benefit | |
| Net loss | |
| Net loss attributable to common stock, basic | |
| Net loss attributable to common stock, diluted | |
| Net loss per share of common stock, basic (in usd per share) | |
| Net loss per share of common stock, diluted (in usd per share) | |
| Weighted average common stock outstanding, basic (in shares) | |
| Weighted average common stock outstanding, diluted (in shares) | |
| Other comprehensive income: | |
| Net unrealized gains on marketable securities | |
| Total other comprehensive income | |
| Total comprehensive loss |
Loading...